We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
(-4%)
Cap. Flow
-$2.79B
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$66.4M |
| 2 |
Valero Energy
VLO
|
+$28.9M |
| 3 |
SLB Ltd
SLB
|
+$24.8M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$22.6M |
| 5 |
PepsiCo
PEP
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$182M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$90.9M |
| 4 |
Amgen
AMGN
|
+$72.1M |
| 5 |
Tesla
TSLA
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.26% |
| 2 | Technology | 28.78% |
| 3 | Financials | 8.15% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
HubSpot
HUBS
$11.4B
| $1.45M | 0.01% |
2,723
-2,940
| -52% | -$1.38M |
|
527
Scotiabank
BNS
$106B
| $1.45M | 0.01% |
28,913
-68,091
| -70% | -$3.38M |
|
528
CDW
CDW
$17.6B
| $1.44M | 0.01% |
7,861
-6,755
| -46% | -$1.18M |
|
529
Baxter International
BAX
$12.1B
| $1.43M | 0.01% |
31,449
-33,051
| -51% | -$1.44M |
|
530
Dr. Reddy's Laboratories
RDY
$9.8B
| $1.39M | 0.01% |
110,000
+20,000
| +22% | +$233K |
|
531
Healthpeak Properties
DOC
$15.5B
| $1.36M | 0.01% |
67,510
-20,843
| -24% | -$433K |
|
532
Ulta Beauty
ULTA
$20.7B
| $1.36M | 0.01% |
2,882
-29,788
| -91% | -$14.6M |
|
|
IRBT
533
DELISTED
iRobot
IRBT
| $1.35M | 0.01% |
29,769
-10,189
| -25% | -$407K |
|
534
Loop Industries
LOOP
$37.3M
| $1.33M | 0.01% |
413,327
| – | – |
|
535
Raymond James Financial
RJF
$33.3B
| $1.32M | 0.01% |
12,710
-10,903
| -46% | -$1.01M |
|
536
Darden Restaurants
DRI
$23.4B
| $1.3M | 0.01% |
7,795
+2,392
| +44% | +$376K |
|
|
LICY
537
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.3M | 0.01% |
29,250
| – | – |
|
538
Reliance Steel & Aluminium
RS
$20.6B
| $1.28M | 0.01% |
4,725
-420
| -8% | -$104K |
|
539
Crocs
CROX
$6.69B
| $1.27M | 0.01% |
11,330
+9,430
| +496% | +$1.12M |
|
540
Tapestry
TPR
$29.8B
| $1.26M | 0.01% |
29,480
-1,687
| -5% | -$70.2K |
|
541
Badger Meter
BMI
$3.71B
| $1.26M | 0.01% |
8,517
-13,725
| -62% | -$1.89M |
|
542
Iron Mountain
IRM
$37.8B
| $1.25M | 0.01% |
22,064
-20,535
| -48% | -$1.12M |
|
543
Stanley Black & Decker
SWK
$14.6B
| $1.25M | 0.01% |
13,362
-11,410
| -46% | -$944K |
|
544
Lennar Class A
LEN
$20.5B
| $1.25M | 0.01% |
10,282
+809
| +9% | +$88.3K |
|
545
Hormel Foods
HRL
$14.3B
| $1.25M | 0.01% |
30,960
-18,962
| -38% | -$760K |
|
546
Maravai LifeSciences
MRVI
$987M
| $1.24M | 0.01% |
100,000
| – | – |
|
547
Builders FirstSource
BLDR
$7.82B
| $1.24M | 0.01% |
+9,138
| New | +$1.02M |
|
548
Cencora
COR
$60.5B
| $1.24M | 0.01% |
6,432
-3,355
| -34% | -$581K |
|
549
Atlassian
TEAM
$24.3B
| $1.22M | 0.01% |
+7,277
| New | +$1.17M |
|
550
Microchip Technology
MCHP
$42.3B
| $1.21M | 0.01% |
13,555
-1,358
| -9% | -$107K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2023 Portfolio in Review
As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.
- Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
- Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
- Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
- Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
- Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
- Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
- Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.
Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.